Lin, Xiaoyan et al
"Slowly Signaling G Protein–Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence." Molecular Pharmacology
93.2
(2018):
49-62.
Web. 17 Sept2024.
